These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1321132)

  • 1. Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.
    Chang CN; Doong SL; Zhou JH; Beach JW; Jeong LS; Chu CK; Tsai CH; Cheng YC; Liotta D; Schinazi R
    J Biol Chem; 1992 Jul; 267(20):13938-42. PubMed ID: 1321132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical pharmacology of (+)- and (-)-2',3'-dideoxy-3'-thiacytidine as anti-hepatitis B virus agents.
    Chang CN; Skalski V; Zhou JH; Cheng YC
    J Biol Chem; 1992 Nov; 267(31):22414-20. PubMed ID: 1331054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.
    Doong SL; Tsai CH; Schinazi RF; Liotta DC; Cheng YC
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8495-9. PubMed ID: 1656445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biochemical basis for the differential anti-human immunodeficiency virus activity of two cis enantiomers of 2',3'-dideoxy-3'-thiacytidine.
    Skalski V; Chang CN; Dutschman G; Cheng YC
    J Biol Chem; 1993 Nov; 268(31):23234-8. PubMed ID: 7693686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-hepatitis B virus activity and metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine.
    Zhu YL; Dutschman DE; Liu SH; Bridges EG; Cheng YC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1805-10. PubMed ID: 9661025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of L-(-)2,3-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues.
    Fu L; Liu SH; Cheng YC
    Biochem Pharmacol; 1999 Jun; 57(12):1351-9. PubMed ID: 10353255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase.
    Liou JY; Krishnan P; Hsieh CC; Dutschman GE; Cheng YC
    Mol Pharmacol; 2003 Jan; 63(1):105-10. PubMed ID: 12488542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase.
    Shewach DS; Liotta DC; Schinazi RF
    Biochem Pharmacol; 1993 Apr; 45(7):1540-3. PubMed ID: 8385948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro.
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    Biochem Pharmacol; 1994 Jan; 47(2):171-4. PubMed ID: 8304960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
    Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells.
    Xie H; Voronkov M; Liotta DC; Korba BA; Schinazi RF; Richman DD; Hostetler KY
    Antiviral Res; 1995 Oct; 28(2):113-20. PubMed ID: 8585765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic studies comparing the incorporation of (+) and (-) isomers of 3TCTP by HIV-1 reverse transcriptase.
    Feng JY; Anderson KS
    Biochemistry; 1999 Jan; 38(1):55-63. PubMed ID: 9890882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro.
    Schinazi RF; Gosselin G; Faraj A; Korba BE; Liotta DC; Chu CK; Mathé C; Imbach JL; Sommadossi JP
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2172-4. PubMed ID: 7811039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular pharmacology of the anti-hepatitis B virus agent beta-L-2',3'-didehydro-2',3'-dideoxy-N4-hydroxycytidine: relevance for activation in HepG2 cells.
    Matthes E; Bünger H
    Antimicrob Agents Chemother; 2010 Jan; 54(1):341-5. PubMed ID: 19917760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs.
    Feng JY; Johnson AA; Johnson KA; Anderson KS
    J Biol Chem; 2001 Jun; 276(26):23832-7. PubMed ID: 11328813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activities and cellular toxicities of modified 2',3'-dideoxy-2',3'-didehydrocytidine analogues.
    Stuyver LJ; Lostia S; Adams M; Mathew JS; Pai BS; Grier J; Tharnish PM; Choi Y; Chong Y; Choo H; Chu CK; Otto MJ; Schinazi RF
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3854-60. PubMed ID: 12435688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
    Furman PA; Davis M; Liotta DC; Paff M; Frick LW; Nelson DJ; Dornsife RE; Wurster JA; Wilson LJ; Fyfe JA
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2686-92. PubMed ID: 1336341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HIV and anti-HBV activity and resistance profile of 2',3'-dideoxy-3'-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109.
    Balzarini J; Wedgwood O; Kruining J; Pelemans H; Heijtink R; De Clercq E; McGuigan C
    Biochem Biophys Res Commun; 1996 Aug; 225(2):363-9. PubMed ID: 8753770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
    Anderson KS
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.